A guide to monitoring and evaluation for collaborative TB/HIV activities
The rapid growth of the human immunodeficiency virus (HIV) epidemic in many countries has resulted in an equally dramatic rise in the estimated number of new tuberculosis (TB) cases. HIV-related TB continues to increase even in countries with well-organized national TB control programmes (NTPs) that are implementing DOTS – the basic package that underpins the Stop TB Strategy. Full DOTS implementation is clearly insufficient to control TB where HIV is fuelling the TB epidemic, and control of HIV infection must therefore become an important concern for NTPs. In recognition of this, TB/HIV collaborative activities have been incorporated as major components of the Stop TB Strategy and the Global Plan to Stop TB. The high morbidity and mortality from TB among people living with HIV make TB case detection, treatment and prevention a priority for national AIDS control programmes (NACPs). TB and HIV infection coexist in many people worldwide, and HIV and TB control programmes need to collaborate to prevent and relieve the resultant suffering.